Clinical trials: Advantage of Using Subcutaneous Route for Methotrexate
Methotrexate Adverse Reaction, Advantage of Using Subcutaneous Route for Methotrexate
Subcuteous Methotrexate in Rheumatoid Arthritis
Methotrexate use is important for the treatment of Rheumatoid arthritis. Some patients can not tolerate oral methotrexate. So subcutaneous may help to overcome it.
- Trial name
- SCMTXRA (NCT07094880)
- Testing
- Tab. Methotrexate 25mg/week, Inj. Methotrexate 25mg/week
- Volunteers
- 45 people
- Sponsor
- Bangladesh Medical University